Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACHILLION PHARMACEUTICALS INC | 5,772,968 | reported | 18 Jan 2013 | tx 5+184,896−2,200,000 |
| Neothetics, Inc. | 3,091,642 | reported | 25 Nov 2014 | tx 12+3,248,959−16,681,051 |
| Orexigen Therapeutics, Inc. | 2,967,415 | reported | 22 Dec 2011 | tx 52+7,797,348−4,684,807 |
| Vanda Pharmaceuticals Inc. | 1,954,450 | reported | 12 Dec 2006 | tx 9+3,224,052 |
| Evoke Pharma Inc | 606,283 | reported | 26 May 2016 | tx 11+1,133,333−1,479,184 |
| REVA Medical, Inc. | 85,186 | reported | 23 Mar 2012 | tx 44+5,489,470−5,239,011 |
| NOVACEA INC | 67,875 | reported | 30 Jan 2009 | tx 22+8,102,174−1,274,500 |
| SANTARUS INC | 64,471 | reported | 06 Apr 2004 | tx 6+2,793,668−2,793,668 |
| ZOGENIX, INC. | 50,000 | reported | 21 May 2014 | tx 25+10,295,086−4,252,587 |
| Clovis Oncology, Inc. | 42,223 | reported | 10 Jun 2021 | tx 55+3,313,803−7,875,007 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2021 | GRANT_AWARD | Clovis Oncology, Inc. | 42,223 | 0.00 USD | deriv |
| 04 Jun 2020 | GRANT_AWARD | Clovis Oncology, Inc. | 40,138 | 0.00 USD | deriv |
| 20 Aug 2019 | PURCHASE | Clovis Oncology, Inc. | 20,000 | 5.97 USD | |
| 16 Aug 2019 | PURCHASE | Clovis Oncology, Inc. | 20,000 | 5.70 USD | |
| 06 Jun 2019 | GRANT_AWARD | Clovis Oncology, Inc. | 28,882 | 0.00 USD | deriv |
| 08 May 2019 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 14 Mar 2019 | SALE | Clovis Oncology, Inc. | 17,056 | 27.79 USD | |
| 18 Mar 2019 | OTHER | Clovis Oncology, Inc. | 10,000 | 0.00 USD | |
| 18 Mar 2019 | OTHER | Clovis Oncology, Inc. | 522 | 0.00 USD | |
| 18 Mar 2019 | OTHER | Clovis Oncology, Inc. | 701 | 0.00 USD | |
| 01 Feb 2019 | OTHER | Clovis Oncology, Inc. | 10,000 | 0.00 USD | |
| 01 Feb 2019 | OTHER | Clovis Oncology, Inc. | 1,000,000 | 0.00 USD | |
| 11 Oct 2018 | GRANT_AWARD | Clovis Oncology, Inc. | 14,770 | 0.00 USD | deriv |
| 23 Aug 2018 | CONVERSION | Bionano Genomics, Inc. | 591,184 | — | |
| 23 Aug 2018 | CONVERSION | Bionano Genomics, Inc. | 337,694 | 4.59 USD | |
| 23 Aug 2018 | PURCHASE | Bionano Genomics, Inc. | 15,000 | 6.13 USD | first after silence |
| 23 Aug 2018 | CONVERSION | Bionano Genomics, Inc. | 6,810,098 | 0.00 USD | deriv |
| 23 Aug 2018 | CONVERSION | Bionano Genomics, Inc. | 2,986,762 | 0.00 USD | deriv |
| 23 Aug 2018 | CONVERSION | Bionano Genomics, Inc. | 5,426,808 | 0.00 USD | deriv |
| 23 Aug 2018 | CONVERSION | Bionano Genomics, Inc. | 6,396,105 | 0.00 USD | deriv |
| 23 Aug 2018 | CONVERSION | Bionano Genomics, Inc. | 3,682,919 | 0.00 USD | deriv |
| 23 Aug 2018 | CONVERSION | Bionano Genomics, Inc. | 15,000 | 0.00 USD | deriv |
| 23 Aug 2018 | PURCHASE | Bionano Genomics, Inc. | — | — | deriv |
| 21 May 2018 | OTHER | Clovis Oncology, Inc. | 5,897 | 0.00 USD | |
| 21 May 2018 | OTHER | Clovis Oncology, Inc. | 32,760 | 0.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 23 Aug 2018.